Outcome and survival in HIV-infected infants with Pneumocystis carinii pneumonia and respiratory failure

Shahid Sheikh, Saroj S. Bakshi, Savita G Pahwa

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

A retrospective chart review (January 1987-December 1994) of cases of histologically proven Pneumocystis carinii pneumonia (PCP) in 9 infants (ages 1.1-7 months) who had perinatally acquired human immunodeficiency-1 virus (HIV) infection was performed. None of the children was suspected of having HIV or had received PCP prophylaxis. Respiratory failure requiring mechanical ventilation developed in all 9 children. Comparison of survivors (5) with nonsurvivors (4) showed no significant differences in the age of onset, weight for length, hemoglobin level, total protein/albumin, lactic dehydrogenase (LDH), liver function tests, lymphocyte numbers and functions, time on mechanical ventilation, treatment received (including the use of steroids), and other complications occurring during the acute phase of pneumonia. The survivors had significantly higher platelet counts than nonsurvivors (mean 516K versus 237K, p = 0.02), a trend toward lower arterial-alveolar (A-a) gradient (mean 415 versus 218, p = 0.07), and earlier use of steroids after the onset of illness (2.5 versus 1 day, p = 0.06). Four of 5 children treated after December 1989 survived compared to 1 of 4 prior to that. Four survivors followed for a median length of 29 months (range 28-32 months) had stable physical and neurocognitive development, improvement in CD4+ T cell counts [mean 27% (range 23-36%), absolute count- mean 1631 (range 1427-1631)] and immunologic functions, and decrease in p24 Ag in 3 of 4. The cellular provital load measured by DNA quantitative polymerase chain reaction (QC-PCR) decreased (40K to 17.3K copies) in one of two patients studied at two time points. PCP continues to be a serious complication of HIV infection in infancy and aggressive preventive approaches seem warranted. In our institution no single factor was responsible for improved survival following PCP after 1989. Four of 5 survivors continued to do well 28-32 months after the acute episode.

Original languageEnglish
Pages (from-to)155-163
Number of pages9
JournalPediatric AIDS and HIV Infection
Volume7
Issue number3
StatePublished - Oct 8 1996
Externally publishedYes

Fingerprint

Pneumocystis Pneumonia
Respiratory Insufficiency
Survivors
HIV-1
Survival
Virus Diseases
Artificial Respiration
Steroids
Polymerase Chain Reaction
Liver Function Tests
Lymphocyte Count
DNA-Directed DNA Polymerase
CD4 Lymphocyte Count
Platelet Count
Age of Onset
Albumins
Pneumonia
Oxidoreductases
Milk
Hemoglobins

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Outcome and survival in HIV-infected infants with Pneumocystis carinii pneumonia and respiratory failure. / Sheikh, Shahid; Bakshi, Saroj S.; Pahwa, Savita G.

In: Pediatric AIDS and HIV Infection, Vol. 7, No. 3, 08.10.1996, p. 155-163.

Research output: Contribution to journalArticle

@article{5df40d11230b4c4aacfa4c887b6f6b0d,
title = "Outcome and survival in HIV-infected infants with Pneumocystis carinii pneumonia and respiratory failure",
abstract = "A retrospective chart review (January 1987-December 1994) of cases of histologically proven Pneumocystis carinii pneumonia (PCP) in 9 infants (ages 1.1-7 months) who had perinatally acquired human immunodeficiency-1 virus (HIV) infection was performed. None of the children was suspected of having HIV or had received PCP prophylaxis. Respiratory failure requiring mechanical ventilation developed in all 9 children. Comparison of survivors (5) with nonsurvivors (4) showed no significant differences in the age of onset, weight for length, hemoglobin level, total protein/albumin, lactic dehydrogenase (LDH), liver function tests, lymphocyte numbers and functions, time on mechanical ventilation, treatment received (including the use of steroids), and other complications occurring during the acute phase of pneumonia. The survivors had significantly higher platelet counts than nonsurvivors (mean 516K versus 237K, p = 0.02), a trend toward lower arterial-alveolar (A-a) gradient (mean 415 versus 218, p = 0.07), and earlier use of steroids after the onset of illness (2.5 versus 1 day, p = 0.06). Four of 5 children treated after December 1989 survived compared to 1 of 4 prior to that. Four survivors followed for a median length of 29 months (range 28-32 months) had stable physical and neurocognitive development, improvement in CD4+ T cell counts [mean 27{\%} (range 23-36{\%}), absolute count- mean 1631 (range 1427-1631)] and immunologic functions, and decrease in p24 Ag in 3 of 4. The cellular provital load measured by DNA quantitative polymerase chain reaction (QC-PCR) decreased (40K to 17.3K copies) in one of two patients studied at two time points. PCP continues to be a serious complication of HIV infection in infancy and aggressive preventive approaches seem warranted. In our institution no single factor was responsible for improved survival following PCP after 1989. Four of 5 survivors continued to do well 28-32 months after the acute episode.",
author = "Shahid Sheikh and Bakshi, {Saroj S.} and Pahwa, {Savita G}",
year = "1996",
month = "10",
day = "8",
language = "English",
volume = "7",
pages = "155--163",
journal = "Pediatric AIDS and HIV Infection",
issn = "1045-5418",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Outcome and survival in HIV-infected infants with Pneumocystis carinii pneumonia and respiratory failure

AU - Sheikh, Shahid

AU - Bakshi, Saroj S.

AU - Pahwa, Savita G

PY - 1996/10/8

Y1 - 1996/10/8

N2 - A retrospective chart review (January 1987-December 1994) of cases of histologically proven Pneumocystis carinii pneumonia (PCP) in 9 infants (ages 1.1-7 months) who had perinatally acquired human immunodeficiency-1 virus (HIV) infection was performed. None of the children was suspected of having HIV or had received PCP prophylaxis. Respiratory failure requiring mechanical ventilation developed in all 9 children. Comparison of survivors (5) with nonsurvivors (4) showed no significant differences in the age of onset, weight for length, hemoglobin level, total protein/albumin, lactic dehydrogenase (LDH), liver function tests, lymphocyte numbers and functions, time on mechanical ventilation, treatment received (including the use of steroids), and other complications occurring during the acute phase of pneumonia. The survivors had significantly higher platelet counts than nonsurvivors (mean 516K versus 237K, p = 0.02), a trend toward lower arterial-alveolar (A-a) gradient (mean 415 versus 218, p = 0.07), and earlier use of steroids after the onset of illness (2.5 versus 1 day, p = 0.06). Four of 5 children treated after December 1989 survived compared to 1 of 4 prior to that. Four survivors followed for a median length of 29 months (range 28-32 months) had stable physical and neurocognitive development, improvement in CD4+ T cell counts [mean 27% (range 23-36%), absolute count- mean 1631 (range 1427-1631)] and immunologic functions, and decrease in p24 Ag in 3 of 4. The cellular provital load measured by DNA quantitative polymerase chain reaction (QC-PCR) decreased (40K to 17.3K copies) in one of two patients studied at two time points. PCP continues to be a serious complication of HIV infection in infancy and aggressive preventive approaches seem warranted. In our institution no single factor was responsible for improved survival following PCP after 1989. Four of 5 survivors continued to do well 28-32 months after the acute episode.

AB - A retrospective chart review (January 1987-December 1994) of cases of histologically proven Pneumocystis carinii pneumonia (PCP) in 9 infants (ages 1.1-7 months) who had perinatally acquired human immunodeficiency-1 virus (HIV) infection was performed. None of the children was suspected of having HIV or had received PCP prophylaxis. Respiratory failure requiring mechanical ventilation developed in all 9 children. Comparison of survivors (5) with nonsurvivors (4) showed no significant differences in the age of onset, weight for length, hemoglobin level, total protein/albumin, lactic dehydrogenase (LDH), liver function tests, lymphocyte numbers and functions, time on mechanical ventilation, treatment received (including the use of steroids), and other complications occurring during the acute phase of pneumonia. The survivors had significantly higher platelet counts than nonsurvivors (mean 516K versus 237K, p = 0.02), a trend toward lower arterial-alveolar (A-a) gradient (mean 415 versus 218, p = 0.07), and earlier use of steroids after the onset of illness (2.5 versus 1 day, p = 0.06). Four of 5 children treated after December 1989 survived compared to 1 of 4 prior to that. Four survivors followed for a median length of 29 months (range 28-32 months) had stable physical and neurocognitive development, improvement in CD4+ T cell counts [mean 27% (range 23-36%), absolute count- mean 1631 (range 1427-1631)] and immunologic functions, and decrease in p24 Ag in 3 of 4. The cellular provital load measured by DNA quantitative polymerase chain reaction (QC-PCR) decreased (40K to 17.3K copies) in one of two patients studied at two time points. PCP continues to be a serious complication of HIV infection in infancy and aggressive preventive approaches seem warranted. In our institution no single factor was responsible for improved survival following PCP after 1989. Four of 5 survivors continued to do well 28-32 months after the acute episode.

UR - http://www.scopus.com/inward/record.url?scp=0029810015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029810015&partnerID=8YFLogxK

M3 - Article

C2 - 11361582

AN - SCOPUS:0029810015

VL - 7

SP - 155

EP - 163

JO - Pediatric AIDS and HIV Infection

JF - Pediatric AIDS and HIV Infection

SN - 1045-5418

IS - 3

ER -